HIGHLIGHTS
- who: Isabelle Mohr from the Department of Pathology, Heidelberg University Hospital, Heidelberg, Germany have published the article: Clinical effects and safety of different transarterial chemoembolization methods for bridging and palliative treatments in hepatocellular carcinoma, in the Journal: (JOURNAL)
- what: This study has some limitations due to patient cohorts (bridging vs. palliative collective) and due to variant TACE procedures (different particle size, different area of embolization, amount of embolisate, selective vs. unselective TACE).
- how: The retrospective cohort study was conducted in a tertiary care center (Heidelberg University Hospital) and was approved by the institutional . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.